Type 2 Diabetes Serum

All filters

Format

Format

Format
Volume / Size

Volume / Size

Volume / Size
Condition

Condition

Condition

Start typing to see matching condition.

Donor Demographics

Donor Demographics

Gender
Age Range
Race / Ethnicity

Start typing to see matching race / ethnicity.

Country of Collection
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot #

Start typing to see matching lot #.

Patient ID

Start typing to see matching patient id.

8 lots match
8 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Diabetes Type II Serum 82078 151001 Female 61+ Asian/Pacific Islander Frozen 1 mL 8 — Metformin 500mg BID amLODIPine-Olmesartan 5-20 MG QD Diabetes Type II United States 2026 11:01:01G/33:03:01G 15:02:01G/58:01:01G 03:02:01G/08:01:01G 12:02:01G/16:02:01G — 01:02:01G/06:01:01G 03:01:01G/05:02:01G 01:03:01G/02:01:01G 14:01:01G/21:01:01G 274704; 274705; 274703; 274701; 274698; 274702; 274699; 274700Serum1.0 MLDiabetes Type IIDiabetes Type 2YesSeasonal24.89ReactiveYesNoNoNoNoNOYesORH+StoredIn Stock
$316
Diabetes Type II Serum 81256 148805 Male 61+ African American Frozen 1 mL 4 — Alopurinol 100mg QD Atorvastatin 20mg QD Tamsulosin 4mg QD Gout, Diabetes Type II United States 2026 A*02:01:01:01/A*- — — — — — — — — 271444; 271442; 271443; 271441Serum1.0 MLDiabetes Type IIDiabetes Type 2;GoutNo39.58ReactiveYesYesNoNoNoNOYesORH+StoredIn Stock
$316
Diabetes Type II Serum 79687 152071 Male 61+ Asian/Pacific Islander Frozen 1 mL 4 — Metformin HCL 1000mg 2/day Atonvastatin Calcium 20mg 1/day Cholecalcif 50MCG 1/day Tamsulosin HCL0.4 MG 1/day Finasteride 5 MG 1/day Diabetes Type II United States 2026 A*26:01:01:01/A*33:03:01:01 — — — — — — — — 214370; 214372; 214371; 214369Serum1.0 MLDiabetes Type IIDiabetes Type 2No27.44ReactiveYesNoNoYes-Currently Smokes0.75NoNOYesBRH+StoredIn Stock
$316
Diabetes Type II Serum 77414 148805 Male 61+ African American Frozen 1 mL 4 — Alopurinol 100mg QD Atorvastatin 20mg QD Tamsulosin 4mg QD Gout, Diabetes Type II United States 2026 A*02:01:01:01/A*- — — — — — — — — 206378; 206377; 206376; 206375Serum1.0 MLDiabetes Type IIDiabetes Type 2;GoutNo39.58ReactiveYesYesNoNoNoNOYesORH+StoredIn Stock
$316
Diabetes Type II Serum 64605 148805 Male 61+ African American Frozen 1 mL 5 — Alopurinol 100mg QD Atorvastatin 20mg QD Tamsulosin 4mg QD Gout, Diabetes Type II United States 2025 A*02:01:01:01/A*- — — — — — — — — 109750; 109751; 109752; 109753; 109754Serum1.0 MLDiabetes Type IIDiabetes Type 2;GoutNo39.58ReactiveYesYesNoNoNoNOYesORH+StoredIn Stock
$316
Diabetes Type II Serum 67500 149179 Male 46-60 Caucasian Frozen 1 mL 5 — Jardiance 25mg QD, Metformin 1, 000mg BID, Insulin, Fenofibric acid 135mg QD Crestor 10mg QD, Cozar 25mg QD Diabetes Type II United States 2025 01:01:01G/03:01:01G 08:01:01G/15:01:01G 03:03:01G/07:01:01G 01:01:01G/04:01:01G 01:01:01G 01:01:01G/03:01:01G 03:02:01G/05:01:01G 01:03:01G 04:01:01G/04:02:01G 147288; 147289; 147290; 147291; 147292Serum1.0 MLDiabetes Type IIDiabetes Type 2No25.82ReactiveYesNoNoNoNoNOYesBRH+StoredIn Stock
$316
Diabetes Type II Serum 65314 147884 Male 31-45 Hispanic/Latino Frozen 1 mL 5 — Insulin Levothyroxine 75mg Aspirin 81mg Fish oil supplement Mirtazapine 30mg QD Atorvastatin 40mg Jardiance 10mg Diabetes Type II United States 2025 24:02:01G/30:51 14:01:01G/39:06:02G 07:02:01G/08:02:01G 04:07:01G/12:01:01G 01:01:01G 01:01:01G/03:01:01G 03:02:01G/05:01:01G 01:03:01G 03:01:01G/18:01:01G 110233; 110234; 110235; 110236; 110237Serum1.0 MLDiabetes Type IIDiabetes Type 2No21.41ReactiveYesNoYesOtherNoNoYESYesORH+StoredIn Stock
$316
Diabetes Type II Serum 64332 141144 Male 46-60 African American Frozen 1 mL 4 — Metformin 1, 000mg BID Atorvastatin 20mg QD Diabetes Type II United States 2025 32:01:01G/33:03:01G 44:03:01G/53:01:01G 04:01:01G 04:01:01G/08:04:01G 01:01:01G 03:01:01G/04:01:01G 03:01:01G/03:02:01G 02:01:01G 01:01:01G/01:01:02G 109285; 109286; 109287; 109288Serum1.0 MLDiabetes Type IIDiabetes Type 2No32.95ReactiveYesNoNoNoNoYESYesORH+StoredIn Stock
$316

Showing 1–8 of 8 lots

About Type 2 Diabetes Serum

Type 2 Diabetes Serum is sourced from consented donors with documented diabetes type II. These samples support immunoassay and proteomics research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Diabetes Type II research
  • Immunoassay development
  • Serum proteomic research
  • Metabolomic research
  • Soluble-protein studies

Product Features

  • Human serum
  • Donor condition: Diabetes Type II
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Donor Stratification

Cohort characteristics include diagnosis and documented clinical phenotype, medication history, comorbidities and demographics.

Protocols & Documentation

  • Serum Isolation

    Protocol for serum preparation from whole blood, including collection handling, clarification, and quality documentation.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Serum

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Type 2 Diabetes Serum with normal donor samples for comparison

Healthy Serum

99 In Stock
Screened normal donors · Frozen · Starting at $132
View Inventory

Need a custom Serum cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information